Search results
Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug
Pharmaceutical Technology· 5 days agoIn April, Merck invested over €300m ($320.8m) in a new Life Science Research Center at its global...
In April, Merck invested over €300m ($320.8m) in a new Life Science Research Center at its global...